Определение генетической предрасположенности к наследственным и мультифакториальным заболеваниям. Генетический паспорт // Методические рекомендации. - СПб.: ИКФ ”Фолиант”, 2001. -48с.
Рогозкин В.А., Назаров И.Б., Казаков В.И. Генетические маркеры физической работоспособности человека // Теория и практика физической культуры. - 2000. - №12. – С.34-36.
Рогозкин В.А., Астратенкова И.В., Дружевская А.М., Федотовская О.Н. Гены-маркеры предрасположенности к скоростно-силовым видам спота // Теория и практика физической культуры. - 2005. - №1. - C.2-4.
Федотовская О.Н. Влияние С34T полиморфизма в гене АМФ-дезаминазы (АМPD1) на физическую работоспособность человека // Генетические, психофизические и педагогические технологии подготовки спортсменов. Сб. науч. тр. – СПб. - 2006. – C.74-80.
Шихова Ю.В., Ахметов И.И., Астратенкова И.В. Анализ полиморфизма гена рецептора андрогена у спортсменов // Инновации в науке, образовании и производстве: Труды СПбГТУ № 497., СПб. – 2006. –С.138-142.
Alvarez R., Terrados N., Ortolano R., Iglesias-Cubero G., Reguero J.R., Batalla A., Cortina A., Fernбndez-Garcнa B., Rodrнguez C., Braga S., Alvarez V., Coto E. Genetic variation in the renin-angiotensin system and athletic performance // Eur J Appl Physiol. – 2000. – V.82(1-2). – P.117-20.
Barish G.D., V.A. Narkar, R.M. Evans PPAR delta: a dagger in the heart of the metabolic syndrome// J Clin Invest. – 2006. – V.116(3). – P.590-7.
Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM // Diabetes. – 1997. – V.46. – P.3–10.
Barroso I., J. Luan, M.S. Sandhu, P.W. Franks, V. Crowley, A.J. Schafer, S. O'rahilly, N.J. Wareham Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes // Diabetologia. – 2006. – V.49(3). – P.501-5.
Desvergne, W. Wahli. Peroxisome proliferator-activated receptors: nuclear control of metabolism // Endocr Rev. – 1999. – V.20. – P.649-688.
Finck B.N., C. Bernal-Mizrachi, D.H. Han, T. Coleman, N. Sambandam, L.L. LaRiviere, J.O. Holloszy, C.F. Semenkovich, D.P. Kelly. A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes // Cell Metab. – 2005. – V.1. – P.133–144.
Finck B.N., D.P. Kelly PGC-1 coactivators: inducible regulators of energy metabolism in health and disease // J. Clin. Invest. - 2006. – V.116. - P.615–622.
Flavell D.M., H. Ireland, J.W. Stephens, E. Hawe, J. Acharya, H. Mather, S.J. Hurel, S.E. Humphries Peroxisome proliferator-activated receptor α gene variation influences age of onset and progression of type 2 diabetes / // Diabetes. – 2005. – V.54. - P582-586.
Greene M.E., B. Blumberg, O.W. McBride, H.F. Yi, K. Kronquist, K. Kwan, L. Hsieh, G. Greene, S.D. Nimer Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping // Gene Expr . – 1995. – V.4. – P.281–299.
Handschin C., J. Rhee, J. Lin, P.T. Tarr, B.M. Spiegelman An autoregulatory loop controls peroxisome proliferator activated receptor γ coactivator 1α expression in muscle // PNAS. – 2003. – V.100(12). – P.7111-7116.
Iemitsu M, Miyauchi T, Maeda S et al: Intense exercise causes decrease in expression of both endothelial NO synthase and tissue NOx level in hearts. Am J Physiol Regulatory Integrative Comp Physiol 2000; 279: 951–959.
Lehman J.J., P.M. Barger, A. Kovacs, J.E. Saffitz, D.M. Medeiros, D.P. Kelly PPARγ coactivator-1 (PGC-1) promotes cardiac mitochondrial biogenesis // J. Clin. Invest. – 2000. – V.106. – P.847–856.
Loviscach M., N. Rehman, L. Carter, S. Mudaliar, P. Mohadeen, T.P. Ciaraldi, J.H. Veerkamp, R.R. Henry Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action // Diabetologia. – 2000. – V.43(3). – P.304-11.
Lucia A., F. Gomez-Gallego, I. Barroso, M. Rabadan, F. Bandres, A.F. San Juan, J.L. Chicharro, U. Ekelund, S. Brage, C.P. Earnest, N.J. Wareham, P.W. Franks PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men // J Appl Physiol. – 2005. – V.99(1). – P.344-8.
Masud S., S. Ye Effect of the peroxisome proliferator-activated receptor-γ gene Pro12Ala variant on body mass index: a meta-analysis / // Journal of medical genetics. – 2003. - V.40. – P.773-780.
Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Brynes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., Humphries S.E. Human gene for physical performance // Nature. – 1998. – V.393. – P.221-222.
Moran C.N., C. Vassilopoulos, A. Tsiokanos, et al. // The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents // Eur. J. Hum. Genet. – 2006. – V.3. – P.1–8.
Nazarov I.B., Woods D.R., Montgomery H.E., Shneider O.V., Kazakov V.I., Tomilin N.V., Rogozkin V.A. The angiotensin converting enzyme I/D polymorphism in Russian athletes // Eur. J. Hum. Genet. 2001. V. 9. P. 797-801.
Nicklas B.J. , E.F. van Rossum, D.M. Berman, A.S. Ryan, K.E. Dennis, A.R. Shuldiner Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain // Diabetes. – 2001. – V.50(9). – P.2172-6.
Norman B, Mahnke-Zizelman DK, Vallis A, and Sabina RL. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 85:1273–1278, 1998.
North K., Nan Yang, Mills M. A common nonsense mutation results in .-actinin-3 deficiency in general population.//Nature genetics.1999.V.21,April.P.353-354
Rankinen T., Bray M.S., Hagberg J.M., Perusse L., Roth S.M., Wolfarth B., Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc. – 2006. – V.38(11). –P.1863-1888.
Ridderstrale M., L.E. Johansson, L. Rastam, U. Lindblad Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men // Diabetologia. – 2006. – V.49(3). – P.496-500.
Russell A.P., J. Feilchenfeldt, S. Schreiber, M. Praz, A. Crettenand, C. Gobelet, C.A. Meier, D.R. Bell, A. Kralli, J.P. Giacobino, O. Deriaz. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle // Diabetes. – 2003. – V.52. – P.2874-2881.
Semple R.K., V.K. Chatterjee, S. O'Rahilly PPAR gamma and human metabolic disease // J Clin Invest. – 2006. – V.116(3). – P.581-9.
Simoneau J.-A, C. Bouchard. Genetic determinism of fiber type proportion in human skeletal muscle // FASEB J. – 1995. – V.9. – P.1091-1095.
Skogsberg J., K. Kannisto, T.N. Cassel, A. Hamsten, P. Eriksson, E. Ehrenborg Evidence That Peroxisome Proliferator–Activated Receptor Delta Influences Cholesterol Metabolism in Men // Arteriosclerosis, Thrombosis, and Vascular Biology. – 2003. - V.23. – P.637-43. (a)
Stumvoll M., H. Haring // The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism / Diabetes. – 2002. – V.51(8). – P.2341-7.
Williams AG, Day SH, Folland JP et al. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc., 2005, V.37, N6, P.944-948.
Wolfarth B., Rankinen T., Mьhlbauer S., Scherr J., Boulay M.R., Pйrusse L., Rauramaa R., Bouchard C. Association between a beta2-adrenergic receptor polymorphism and elite endurance performance // Metabolism. – 2007. –V.56(12). – P.1649-51.
Yang N., Daniel G.M., Jason P.G. ACTN3 genotype is associated with human elite performance // American J. Human Genetetics. - 2003. - V.73. - P.627-631.
